Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie L Goff

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025
Facts and Hopes for Neoantigen-Enriched TILSiqi C Brough, Kristen L Skonieczny, Stav Leibou, et al.
JCO Clinical Cancer Informatics|July 8, 2025
Assessing the Data Quality Dimensions of Surgical Oncology Cohorts in the <i>All of Us</i> Research ProgramMatthew Spotnitz, John Giannini, Emily Clark, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Risk of bowel perforation in patients receiving interleukin-2 after therapy with anti-CTLA 4 monoclonal antibodyFranz O Smith, Stephanie L Goff, Jacob A Klapper, et al.
JMIR Cancer|March 11, 2025
Assessing the Data Quality Dimensions of Partial and Complete Mastectomy Cohorts in the <i>All of Us</i> Research Program: Cross-Sectional StudyMatthew Spotnitz, John Giannini, Yechiam Ostchega, et al.
World Journal of Gastrointestinal Surgery|August 29, 2013
Small bowel carcinoid: Location isn't everything!Danielle M Hari, Stephanie L Goff, Heidi J Reich, et al.
Blood Advances|July 21, 2025
Survival after anti-CD19 CAR T-cell therapy for B-cell non-Hodgkin lymphoma and CLL with 10 years of follow-upTatyana Gavrilova, Lori McIntyre, Stephanie L Goff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2020
Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell TherapyKathryn M Cappell, Richard M Sherry, James C Yang, et al.
Cancer Immunology, Immunotherapy : CII|July 15, 2010
Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansionStephanie L Goff, Laura A Johnson, Mary A Black, et al.
Leukemia & Lymphoma|June 9, 2022
Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experienceSamantha J Seitter, Paul H McClelland, Mark A Ahlman, et al.
Human Gene Therapy Methods|April 21, 2012
A simple and effective method to generate lentiviral vectors for ex vivo gene delivery to mature human peripheral blood lymphocytesShicheng Yang, Neel K Karne, Stephanie L Goff, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025
Facts and Hopes for Neoantigen-Enriched TILSiqi C Brough, Kristen L Skonieczny, Stav Leibou, et al.
JCO Clinical Cancer Informatics|July 8, 2025
Assessing the Data Quality Dimensions of Surgical Oncology Cohorts in the <i>All of Us</i> Research ProgramMatthew Spotnitz, John Giannini, Emily Clark, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Risk of bowel perforation in patients receiving interleukin-2 after therapy with anti-CTLA 4 monoclonal antibodyFranz O Smith, Stephanie L Goff, Jacob A Klapper, et al.
JMIR Cancer|March 11, 2025
Assessing the Data Quality Dimensions of Partial and Complete Mastectomy Cohorts in the <i>All of Us</i> Research Program: Cross-Sectional StudyMatthew Spotnitz, John Giannini, Yechiam Ostchega, et al.
World Journal of Gastrointestinal Surgery|August 29, 2013
Small bowel carcinoid: Location isn't everything!Danielle M Hari, Stephanie L Goff, Heidi J Reich, et al.
Blood Advances|July 21, 2025
Survival after anti-CD19 CAR T-cell therapy for B-cell non-Hodgkin lymphoma and CLL with 10 years of follow-upTatyana Gavrilova, Lori McIntyre, Stephanie L Goff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2020
Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell TherapyKathryn M Cappell, Richard M Sherry, James C Yang, et al.
Cancer Immunology, Immunotherapy : CII|July 15, 2010
Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansionStephanie L Goff, Laura A Johnson, Mary A Black, et al.
Leukemia & Lymphoma|June 9, 2022
Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experienceSamantha J Seitter, Paul H McClelland, Mark A Ahlman, et al.
Human Gene Therapy Methods|April 21, 2012
A simple and effective method to generate lentiviral vectors for ex vivo gene delivery to mature human peripheral blood lymphocytesShicheng Yang, Neel K Karne, Stephanie L Goff, et al.
Pageof 6